Glen Harbor Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.44M | Sell |
10,880
-6,834
| -39% | -$905K | 0.03% | 391 |
|
|
2019
Q2 | $2.51M | Buy |
17,714
+3,910
| +28% | +$555K | 0.05% | 295 |
|
|
2019
Q1 | $2.01M | Buy |
13,804
+4,148
| +43% | +$602K | 0.04% | 319 |
|
|
2018
Q4 | $1.09M | Sell |
9,656
-2,312
| -19% | -$262K | 0.03% | 414 |
|
|
2018
Q3 | $1.61M | Buy |
11,968
+1,632
| +16% | +$220K | 0.03% | 374 |
|
|
2018
Q2 | $1.16M | Sell |
10,336
-5,372
| -34% | -$603K | 0.02% | 402 |
|
|
2018
Q1 | $1.68M | Sell |
15,708
-102
| -0.6% | -$10.9K | 0.04% | 314 |
|
|
2017
Q4 | $1.73M | Buy |
15,810
+9,078
| +135% | +$993K | 0.04% | 327 |
|
|
2017
Q3 | $727K | Buy |
6,732
+1,020
| +18% | +$110K | 0.02% | 481 |
|
|
2017
Q2 | $578K | Buy |
5,712
+680
| +14% | +$68.8K | 0.01% | 554 |
|
|
2017
Q1 | $452K | Sell |
5,032
-204
| -4% | -$18.3K | 0.01% | 579 |
|
|
2016
Q4 | $399K | Buy |
+5,236
| New | +$399K | 0.01% | 558 |
|